...-antihypertensive treatment, and 67 of 76 (88%) on therapeutic oral anticoagulation received prothrombin complex concentrate treatment (PCC). Forty-six patients (14%) received any neurosurgical intervention within 3 h of admission. Median treatment times from admission to first IV-antihypertensive treatment were 38...

... in patients with variants of CYP2C19; (10) aspirin pseudoresistance due to enteric coating; (11) rationale for anticoagulation in patients with embolic stroke of unknown source; (12) pharmacologic properties of direct-acting oral anticoagulants that should be considered when choosing among them; (13...

... reported a low rate of major adverse cardiac events (MACEs) in patients with CeAD, with no significant difference between patients randomized to anticoagulation or antiplatelet therapy. Objective: To compare the effectiveness of anticoagulation and antiplatelet therapy in patients with CeAD. Methods: All...

... with venous thromboembolism (VTE), compared to VKAs, direct oral anticoagulants (DOACs) offer several advantages. However, there is little data concerning their use in managing CVT. Aims: This retrospective observational study pursued 2 objectives: (1) to investigate clinical characteristics of CVT patients...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cerebral venous thrombosis Anticoagulation Coagulation abnormalities...

... with cerebral venous thrombosis (CVT) are rare. Posterior fossa lesions are an independent predictor of death in CVT. We aim to describe the characteristics and outcome of patients with CVT and isolated posterior fossa lesions and assess the safety of anticoagulation in patients with posterior fossa lesions...

...Fan Z. Caprio; Richard A. Bernstein; Mark J. Alberts; Yvonne Curran; Deborah Bergman; Alexander W. Korutz; Faiz Syed; Sameer A. Ansari; Shyam Prabhakaran Background: American and European guidelines support antiplatelet agents and anticoagulants as reasonable treatments of cervical artery...

...A. Machet; A.C. Fonseca; C. Oppenheim; E. Touzé; J.-F. Meder; J.-L. Mas; O. Naggara Background: In case of spontaneous cervical artery dissection (CAD), a medical treatment with anticoagulant or antiplatelet (AP) drugs would avoid the occurrence of an ischemic stroke. Although immediate...

...Vinayak Prasad; Rachel M. Kaplan; Rod S. Passman Atrial fibrillation (AF) is the most common sustained arrhythmia, affects over 2.5 million people in the USA and is responsible for one fifth of the 700,000 ischemic strokes per year. For the last 50 years, long-term anticoagulation with warfarin has...

...%) overall received antiplatelet agents, and 12 (2.4%) received oral anticoagulation. No difference could be found for recurrent ICH under antiplatelet agents versus no antithrombotic medication. Conclusion: The risk of recurrent stroke after lobar ICH remains high beyond the first year, whereas it decreases...

...Joachim Röther; Harry Crijns Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is associated with increased cardiovascular mortality and morbidity, including stroke. Results: Rate or rhythm control and prevention of thromboembolism with oral anticoagulants...

.... Anticoagulation Cardiac myxoma Embolic infarction Intracranial hematoma MRI Cerebrovascular Diseases Case Report Cerebrovasc Dis 1997;7:239-241 Received: October 10, 1996 Accepted: November 12,1996 Ingeborg Schaflialter-Zoppotha Franz Fazekash z Peter K apeller^ Anita Lechnerb Bruno Riglera Hans...

...-associated stroke occurred in one third of all patients and was associated with a distinct profile of recurrent, severe and disabling stroke. Targeted strategies to increase anticoagulation rates may provide a substantial benefit to prevent severe disabling stroke at a population level. 6 04 2009 8...

... and acquired coagulopathies (factor V Leiden mutation/resistance to activated protein C, prothrombin mutation, deficiencies of protein C, protein S, antithrombin III, anticardiolipin IgG antibodies, lupus anticoagulant) had been performed were included. Biannual follow-up in 339 (79%) of these patients...

... medication to ICH features. Some studies have reported a high percentage of cerebellar hemorrhage among patients receiving anticoagulation medication (14–38%) [ 3, 24, 25 ], while others have reported a low percentage (1–6%) [ 1, 26, 27 ]. In our previous study involving 327 ICH patients [ 28 ], warfarin...

.... Methods: We describe 130 patients with angiographically-proven DCA admitted to the Neurology Institute in Mexico City (Mexico), and analyzed clinical and neuroimaging data, treatment and outcome. Treatment with either anticoagulation or aspirin was decided by the primary physician. Primary outcome...

... to other ethnic groups. This study aimed to determine the optimal intensity of anticoagulation for stroke prevention in Chinese patients. Methods: We performed a retrospective study on all Chinese patients with AF taking warfarin for stroke prevention in our hospital from January 1, 2000, to June 30, 2002...

...Francisco Rubio; Mario Jato Oral anticoagulants are drugs commonly used in the prevention of vascular diseases, especially in embolic-type processes. Although several studies have assessed the possibility of using them in arterial processes, the experience has not been satisfactory so far. Heart...

... were compared between patients with and without new thrombi on follow-up TEE. Similar comparisons were made in patients with and without disappearance of thrombi on the follow-up TEE. The effect of anticoagulants was evaluated. Results: Intracardiac thrombi were found initially in 18% (95% CI 11–25...

... of tirofiban 24 h after initial symptom onset [ESS 88], 3 h after neurological deterioration [ESS 84]). The patient was continuously anticoagulated with intravenous heparin with an aPTT accidentally prolonged to 3.5-fold above baseline level for about 24 h before taking the CT scan, 7 days after the end...